Tidalsense raised $19 million to expand adoption of N-Tidal Diagnose, an AI-powered platform designed to identify COPD in about five minutes. The diagnostic workflow combines rapid acquisition and model-driven decision support intended to deliver earlier detection and faster triage outside specialist settings. The financing underscores continuing investor demand for deployable AI diagnostics that can shorten time to diagnosis for chronic respiratory diseases.